미국의 장기 기증 및 이식 소프트웨어 시장 규모, 점유율, 동향 분석 보고서 : 소프트웨어 유형별, 도입 형태별, 용도별, 최종 용도별, 부문별 예측(2026-2033년)

U.S. Organ Donation And Transplant Software Market Summary

The U.S organ donation and transplant software market size was estimated at USD 57.16 million in 2025 and is projected to reach USD 90.04 million by 2033, growing at a CAGR of 5.9% from 2026 to 2033. This growth is attributed to the increasing organ transplant volumes and demand, growing prevalence of end-stage organ diseases, regulatory requirements for standardized data reporting and registry submission, and need for faster, more accurate donor-recipient matching.

Increasing organ transplant volumes in the U.S. are significantly accelerating the adoption of organ donation and transplant software. According to United Network for Organ Sharing, more than 48,000 organ transplants were performed in the U.S. in 2024, with a 55% increase in transplant procedures since 2015, highlighting the expanding scale and complexity of national transplant operations. This rise places substantial pressure on OPOs and transplant centers to manage larger donor pools, higher match-run frequencies, faster decision cycles, and more intricate logistics workflows. As a result, advanced software solutions are increasingly required to streamline donor management, automate allocation and matching, enhance data accuracy, ensure regulatory compliance, and support real-time coordination across the entire transplant ecosystem.

Regulatory requirements for standardized data reporting and registry submission are a major driver of the U.S. organ donation and transplant software market. Transplant centers, OPOs, and histocompatibility labs must submit comprehensive and timely clinical, operational, and outcome data to national bodies such as the OPTN/UNOS and the HRSA, covering donor characteristics, match runs, organ offers, transplant events, and long-term post-transplant follow-up.

These mandatory reporting obligations, along with strict audit trails, quality metrics, and compliance standards, create a need for software platforms that can automate data capture, ensure accuracy, maintain interoperability with EHRs and laboratory systems, and streamline registry submissions. As regulatory scrutiny and data transparency expectations continue to increase, organizations are turning to advanced digital solutions to reduce administrative burden, avoid compliance gaps, and ensure consistent, standardized reporting across the transplant continuum.

Integration of AI in U.S. Healthcare Organ Donation & Transplant Software market

The integration of AI into organ donation and transplant workflows is driving strong adoption of advanced digital platforms in the U.S., as transplant centers and OPOs increasingly rely on intelligent tools to improve donor-recipient matching accuracy, accelerate decision-making, and enhance overall transplant outcomes. AI enables predictive analytics, automated risk scoring, faster data processing, and more efficient coordination across clinical and operational teams. LifeFuser is a secure, cloud-based AI-driven transplant management platform by Ataims Tech designed to optimize organ transplant workflows, including donor-recipient matching and real-time analytics.

It supports all phases of organ transplantation with predictive outcome modeling, customizable workflows, and comprehensive data integration across kidney, liver, heart, lung, and pancreas programs, while ensuring HIPAA and GDPR compliance. Such platforms demonstrate how AI is reshaping transplant operations and contributing to the growth of the U.S. organ donation and transplant software market.

U.S. Healthcare Organ Donation And Transplant Software Market Report Segmentation

This report forecasts revenue growth at regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. healthcare organ donation and transplant software market report based software type, deployment mode, application, and end-use:

• Software Type Outlook (Revenue, USD Million, 2021 - 2033)
• Organ Donor Management Systems
• Transplant Management Systems
• Organ Allocation & Matching Platforms
• Organ Procurement & Logistics Software
• Others
• Deployment Mode Outlook (Revenue, USD Million, 2021 - 2033)
• Cloud-based
• On-premise
• Application Outlook (Revenue, USD Million, 2021 - 2033)
• Organ Donation Workflow Automation
• Waitlist & Recipient Management
• Transplant Coordination & Scheduling
• Regulatory Reporting & Compliance
• Outcome & Data Analytics
• End-use Outlook (Revenue, USD Million, 2021 - 2033)
• Hospitals & Transplant Centers
• Organ Procurement Organizations (OPOs)
• National/Regional Health Agencies
• Research & Academic Institutes

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Software Type
  • 1.2.2. Deployment Mode
  • 1.2.3. Application
  • 1.2.4. End use
• 1.3. Estimates and Forecast Timeline
• 1.4. Research Methodology
• 1.5. Information Procurement
  • 1.5.1. Purchased Database
  • 1.5.2. GVR's Internal Database
  • 1.5.3. Secondary Sources
  • 1.5.4. Primary Research
• 1.6. Information Analysis
  • 1.6.1. Data Analysis Models
• 1.7. Market Formulation & Data Visualization
• 1.8. Model Details
  • 1.8.1. Commodity Flow Analysis
• 1.9. List of Secondary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Snapshot
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Increasing organ transplant volumes and demand
    • 3.2.1.2. Growing prevalence of end-stage organ diseases
    • 3.2.1.3. Regulatory requirements for standardized data reporting and registry submission
    • 3.2.1.4. Need for faster, more accurate donor-recipient matching
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. High implementation and maintenance costs of advanced software platforms.
    • 3.2.2.2. Limited IT infrastructure and digital readiness in smaller hospitals or OPOs.
  • 3.2.3. Industry Opportunity Analysis
  • 3.2.4. Industry Challenge Analysis
  • 3.2.5. Technology Overview
  • 3.2.6. Regulatory Overview
• 3.3. Business Environment Analysis
  • 3.3.1. Porter's Five Forces Analysis
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTLE Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Economic and Social landscape
    • 3.3.2.3. Technological landscape
    • 3.3.2.4. Environmental landscape
    • 3.3.2.5. Legal Landscape

Chapter 4. U.S. Organ Donation and Transplant Software Market: Software Type Estimates & Trend Analysis

• 4.1. Solution Segment Dashboard
• 4.2. Solution Market Share Movement Analysis, 2025 & 2033
• 4.3. Market Size & Forecasts and Trend Analysis, by Solution, 2021 to 2033 (USD Million)
• 4.4. Organ Donor Management Systems
  • 4.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.5. Transplant Management Systems
  • 4.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.6. Organ Allocation & Matching Platforms
  • 4.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.7. Organ Procurement & Logistics Software
  • 4.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.8. Others (Registry & Data Management System, etc.)
  • 4.8.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. U.S. Organ Donation and Transplant Software Market: Deployment Mode Estimates & Trend Analysis

• 5.1. Deployment Mode Segment Dashboard
• 5.2. Deployment Mode Market Share Movement Analysis, 2025 & 2033
• 5.3. Market Size & Forecasts and Trend Analysis, by End Use, 2021 to 2033 (USD Million)
• 5.4. Cloud-based
  • 5.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.5. On-premise
  • 5.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. U.S. Organ Donation and Transplant Software Market: Application Estimates & Trend Analysis

• 6.1. Application Segment Dashboard
• 6.2. Application Market Share Movement Analysis, 2025 & 2033
• 6.3. Market Size & Forecasts and Trend Analysis, by Application, 2021 to 2033 (USD Million)
• 6.4. Organ Donation Workflow Automation
  • 6.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.5. Waitlist & Recipient Management
  • 6.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.6. Transplant Coordination & Scheduling
  • 6.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.7. Regulatory Reporting & Compliance
  • 6.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.8. Outcome & Data Analytics
  • 6.8.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. U.S. Healthcare Organ Donation and Transplant Software Market: End Use Estimates & Trend Analysis

• 7.1. End use Segment Dashboard
• 7.2. End use Market Share Movement Analysis, 2025 & 2033
• 7.3. Market Size & Forecasts and Trend Analysis, by End use, 2021 to 2033 (USD Million)
• 7.4. Hospitals & Transplant Centers
  • 7.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 7.5. Organ Procurement Organizations (OPOs)
  • 7.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 7.6. National/Regional Health Agencies
  • 7.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 7.7. Research & Academic Institutes
  • 7.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Company Market Position Analysis
• 8.2. Company Categorization
• 8.3. Company Profiles/Listing
  • 8.3.1. InVita Healthcare Technologies
    • 8.3.1.1. Participant Overview
    • 8.3.1.2. Financial performance
    • 8.3.1.3. Product benchmarking
    • 8.3.1.4. Strategic initiatives
  • 8.3.2. XVIVO
    • 8.3.2.1. Participant Overview
    • 8.3.2.2. Financial performance
    • 8.3.2.3. Product benchmarking
    • 8.3.2.4. Strategic initiatives
  • 8.3.3. CareDx
    • 8.3.3.1. Participant Overview
    • 8.3.3.2. Financial performance
    • 8.3.3.3. Product benchmarking
    • 8.3.3.4. Strategic initiatives
  • 8.3.4. Afflo
    • 8.3.4.1. Participant Overview
    • 8.3.4.2. Financial performance
    • 8.3.4.3. Product benchmarking
    • 8.3.4.4. Strategic initiatives
  • 8.3.5. Ataims Tech
    • 8.3.5.1. Participant Overview
    • 8.3.5.2. Financial performance
    • 8.3.5.3. Product benchmarking
    • 8.3.5.4. Strategic initiatives
  • 8.3.6. MedSleuth, Inc.
    • 8.3.6.1. Participant Overview
    • 8.3.6.2. Financial performance
    • 8.3.6.3. Product benchmarking
    • 8.3.6.4. Strategic initiatives
  • 8.3.7. EDITLife
    • 8.3.7.1. Participant Overview
    • 8.3.7.2. Financial performance
    • 8.3.7.3. Product benchmarking
    • 8.3.7.4. Strategic initiatives
  • 8.3.8. Buckeye Transplant Solutions
    • 8.3.8.1. Participant Overview
    • 8.3.8.2. Financial performance
    • 8.3.8.3. Product benchmarking
    • 8.3.8.4. Strategic initiatives
  • 8.3.9. United Network for Organ Sharing
    • 8.3.9.1. Participant Overview
    • 8.3.9.2. Financial performance
    • 8.3.9.3. Product benchmarking
    • 8.3.9.4. Strategic initiatives